CA2899126A1 - Tissue patches and associated systems, kits, and methods - Google Patents

Tissue patches and associated systems, kits, and methods Download PDF

Info

Publication number
CA2899126A1
CA2899126A1 CA2899126A CA2899126A CA2899126A1 CA 2899126 A1 CA2899126 A1 CA 2899126A1 CA 2899126 A CA2899126 A CA 2899126A CA 2899126 A CA2899126 A CA 2899126A CA 2899126 A1 CA2899126 A1 CA 2899126A1
Authority
CA
Canada
Prior art keywords
patch
fibrin
matrix
fibrinogen
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2899126A
Other languages
English (en)
French (fr)
Inventor
Daniel Grant ERICSON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xcede Technologies Inc
Original Assignee
Xcede Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xcede Technologies Inc filed Critical Xcede Technologies Inc
Publication of CA2899126A1 publication Critical patent/CA2899126A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/34—Oils, fats, waxes or natural resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA2899126A 2012-02-03 2013-02-01 Tissue patches and associated systems, kits, and methods Abandoned CA2899126A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201261594898P 2012-02-03 2012-02-03
US61/594,898 2012-02-03
US13/644,907 2012-10-04
US13/644,868 US20130202656A1 (en) 2012-02-03 2012-10-04 Systems and kits for the fabrication of tissue patches
US13/644,889 2012-10-04
US13/644,907 US20130202675A1 (en) 2012-02-03 2012-10-04 Systems and methods for the fabrication of tissue patches
US13/644,868 2012-10-04
US13/644,889 US8999376B2 (en) 2012-02-03 2012-10-04 Tissue patch
PCT/US2013/024322 WO2013116633A2 (en) 2012-02-03 2013-02-01 Tissue patches and associated systems, kits, and methods

Publications (1)

Publication Number Publication Date
CA2899126A1 true CA2899126A1 (en) 2013-08-08

Family

ID=48903090

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2899126A Abandoned CA2899126A1 (en) 2012-02-03 2013-02-01 Tissue patches and associated systems, kits, and methods

Country Status (7)

Country Link
US (7) US20130202675A1 (enExample)
EP (1) EP2809362A2 (enExample)
JP (1) JP6329084B2 (enExample)
KR (1) KR20140121873A (enExample)
AU (2) AU2013214974B2 (enExample)
CA (1) CA2899126A1 (enExample)
WO (1) WO2013116633A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8109993B2 (en) * 2006-05-25 2012-02-07 Deep Vein Medical, Inc. Device for regulating blood flow
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
KR20140082646A (ko) * 2011-08-15 2014-07-02 메코롯 워터 컴퍼니 엘티디. 압력 용기 내에서 막 요소를 조정하는 방법
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
CA2956693A1 (en) * 2014-08-08 2016-02-11 Xcede Technologies, Inc. Adhesive compositions and patches, and associated systems, kits, and methods
US9603967B2 (en) * 2015-05-08 2017-03-28 Vivex Biomedical, Inc. Placental tissue assembly
WO2017027378A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US10751444B2 (en) 2015-08-07 2020-08-25 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
US10660945B2 (en) 2015-08-07 2020-05-26 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
WO2019083863A1 (en) 2017-10-23 2019-05-02 Patent Holding Company 001, Llc DEVICES, METHODS, AND COMMUNICATION SYSTEMS
CN109330654B (zh) * 2018-08-31 2021-02-05 华中科技大学 一种止血针、其制备方法和应用
US12115356B2 (en) 2019-03-06 2024-10-15 Gambro Lundia Ab Device and method for the delivery of a thrombin activated fibrin sealant
US11666682B2 (en) 2020-08-31 2023-06-06 Ethicon, Inc. Method of stopping CSF leaks and apparatus therefor
US11934583B2 (en) 2020-10-30 2024-03-19 Datafeel Inc. Wearable data communication apparatus, kits, methods, and systems
WO2022157552A1 (en) * 2021-01-19 2022-07-28 Aegis Lifesciences Pvt. Ltd. Composition and processes of preparation of flowable hemostatic matrix
US20250049984A1 (en) * 2023-08-11 2025-02-13 Ethicon, Inc. Absorbable Dressings for Sealing Sensitive Neural Tissue and Dura Matter

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533004A (en) 1943-10-27 1950-12-05 John D Ferry Fibrin clots and methods for preparing the same
US2492458A (en) 1944-12-08 1949-12-27 Jr Edgar A Bering Fibrin foam
US2576006A (en) * 1947-11-29 1951-11-20 Research Corp Methods of forming shaped fibrin products
US3523807A (en) 1966-11-25 1970-08-11 Mihaly Gerendas Method of making a cross-linked fibrin prosthesis
US3558418A (en) 1968-05-22 1971-01-26 Ncr Co Blocking-resistant plasticizer articles,compositions and processes
US4181557A (en) 1971-05-21 1980-01-01 The Lubrizol Corporation Bonding method employing water-activatable adhesive compositions comprising a plasticizer and an N-sulfohydrocarbon-substituted acrylamide polymer
US4359047A (en) * 1979-03-21 1982-11-16 Advance Tapes (U.K.) Limited Gelatinous articles and compositions
US4347841A (en) 1981-03-11 1982-09-07 Human Oltoanyagtermelo Es Kutato Intezet Biological wound covering and method for producing same
US4699146A (en) 1982-02-25 1987-10-13 Valleylab, Inc. Hydrophilic, elastomeric, pressure-sensitive adhesive
US4732755A (en) 1983-01-17 1988-03-22 University Of Health Sciences/The Chicago Medical School Skin burn treatment
DE3622642A1 (de) 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
US4790819A (en) 1987-08-24 1988-12-13 American Cyanamid Company Fibrin clot delivery device and method
US5225473A (en) 1987-11-25 1993-07-06 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesives
US5290552A (en) 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
AT397203B (de) 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
US6706780B2 (en) 1988-05-31 2004-03-16 University Of Florida Method of and composition for preventing tissue damage
US5013769A (en) 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US5318524A (en) 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5219328A (en) 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5292362A (en) 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5209776A (en) 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
AU639844B2 (en) 1990-11-09 1993-08-05 Otsuka Pharmaceutical Co., Ltd. Procaterol-containing plaster
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US7189410B1 (en) 1990-11-27 2007-03-13 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6613324B1 (en) 1991-02-28 2003-09-02 Bristol-Myers Squibb Company Adhesive for the gluing of biological tissues
SE9101853D0 (sv) 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
US6440427B1 (en) 1991-06-17 2002-08-27 Biovitrum Ab Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer
US5792835A (en) 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
US5326350A (en) 1992-05-11 1994-07-05 Li Shu Tung Soft tissue closure systems
DK83092D0 (da) 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
WO1994002183A1 (en) 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
CN1091315A (zh) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
WO1994022503A1 (en) 1993-03-30 1994-10-13 Opperbas Holding B.V. Two component fibrin glue
US5549904A (en) 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
US5795780A (en) 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
US5437292A (en) 1993-11-19 1995-08-01 Bioseal, Llc Method for sealing blood vessel puncture sites
US5686180A (en) 1994-09-29 1997-11-11 Central Products Company Water activated adhesive and paper-plastic tape containing same
US5464471A (en) 1994-11-10 1995-11-07 Whalen Biomedical Inc. Fibrin monomer based tissue adhesive
US5585007A (en) 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
WO1996017633A1 (en) 1994-12-07 1996-06-13 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
CA2207992A1 (en) 1995-01-16 1996-07-25 Genevieve Krack Self-supporting sheet-like material of cross-linked fibrin for preventing post operative adhesions
US5649959A (en) 1995-02-10 1997-07-22 Sherwood Medical Company Assembly for sealing a puncture in a vessel
US5643192A (en) 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
DE19521324C1 (de) 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
US5702715A (en) 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
ATE309006T1 (de) 1996-03-15 2005-11-15 Chemo Sero Therapeut Res Inst Sprühvorrichtung zum aufbringen von gewebeklebstoff
JP2000509307A (ja) 1996-04-30 2000-07-25 メドトロニック，インコーポレイテッド 自己由来フィブリン密封材の製造方法
WO2000062828A1 (en) 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
AU4648697A (en) 1996-09-23 1998-04-14 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US5977313A (en) 1996-10-10 1999-11-02 Quadrant Healthcare Limited Platelet substitutes and conjugation methods suitable for their preparation
US5844087A (en) 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
WO1998022097A2 (en) 1996-11-20 1998-05-28 Bio Advances, Llc Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
FR2757770B1 (fr) 1996-12-30 1999-02-26 Inoteb Procede de preparation d'une colle biologique capable de coaguler par simple addition d'ions calcium
GB9711927D0 (en) 1997-06-09 1997-08-06 Bristol Myers Squibb Co Compositions useful as fibrin sealants
US6015474A (en) 1997-06-20 2000-01-18 Protein Polymer Technologies Methods of using primer molecules for enhancing the mechanical performance of tissue adhesives and sealants
US7745106B2 (en) 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
IT1292410B1 (it) 1997-06-24 1999-02-08 Roberto Beretta Contenitore di pronto impiego per ottenere colla di fibrina autologa
US6007811A (en) 1997-07-01 1999-12-28 Sea Run Holdings, Inc. Method of producing fibrin sealant from clotting factors in fish blood
US6043407A (en) 1997-07-29 2000-03-28 Warner-Lambert Company Debridement pad
US6162241A (en) 1997-08-06 2000-12-19 Focal, Inc. Hemostatic tissue sealants
AT406120B (de) 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
AT407117B (de) 1997-09-19 2000-12-27 Immuno Ag Fibrinschwamm
US6342250B1 (en) 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
CA2308462C (en) 1997-11-17 2009-02-24 Haemacure Corporation Fibrin sealants or adhesives comprising a hyaluronic acid derivative material
EP1037659A4 (en) 1997-12-09 2005-02-09 Bristol Myers Squibb Co FIBRINOLYTIC INHIBITOR FOR SEALANT
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6395288B1 (en) 1998-04-22 2002-05-28 Kent State University Subversion of bacterial resistance by low solubility antibiotics
US6780411B2 (en) 1998-05-01 2004-08-24 Zymogenetics, Inc. Tissue sealant compositions
JP3578627B2 (ja) 1998-05-15 2004-10-20 株式会社ホギメディカル 創傷患部の治癒を促進する組織シーラント
US7335220B2 (en) 2004-11-05 2008-02-26 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
AU2005203703B2 (en) 1998-08-25 2007-05-24 Columbia Laboratories (Bermuda) Limited Bioadhesive progressive hydration tablets
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
BE1012536A3 (fr) 1998-11-04 2000-12-05 Baxter Int Element muni d'une couche de fibrine sa preparation et son utilisation.
US6211296B1 (en) 1998-11-05 2001-04-03 The B. F. Goodrich Company Hydrogels containing substances
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
AU773128B2 (en) 1998-11-18 2004-05-20 Csl Behring Gmbh Stabilised protein preparations for a tissue adhesive
ES2263451T3 (es) 1999-02-12 2006-12-16 Baxter Aktiengesellschaft Metodo para producir un preparado basado en fibrinogeno y fibronectina, asi como composiciones proteinicas que se pueden obtener segun este metodo.
NZ515585A (en) 1999-06-01 2004-06-25 Bristol Myers Squibb Co Prevention of post surgical adhesions using a fibrin monomer sealant
US6916911B1 (en) 1999-08-13 2005-07-12 Omrix Biopharmaceuticals Sa Use of fibrinogen multimers
US6284235B1 (en) 2000-02-11 2001-09-04 National Starch And Chemical Company Investment Holding Corporation Bioadhesive composition
US6465091B1 (en) 2000-03-27 2002-10-15 3M Innovative Properties Company Release article and adhesive article containing a polymeric release material
US6921532B1 (en) 2000-06-22 2005-07-26 Spinal Restoration, Inc. Biological Bioadhesive composition and methods of preparation and use
US6506365B1 (en) 2000-09-25 2003-01-14 Baxter Aktiengesellschaft Fibrin/fibrinogen binding conjugate
WO2002030445A2 (en) 2000-10-13 2002-04-18 Baxter International Inc. Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
CA2325842C (en) 2000-11-02 2007-08-07 Lisa Mckerracher Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7803392B2 (en) 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US6733774B2 (en) 2001-01-25 2004-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
JP4339593B2 (ja) 2001-02-21 2009-10-07 コロプラスト アクティーゼルスカブ 接着剤組成物
US6942880B1 (en) 2001-04-09 2005-09-13 Medtronic, Inc. Autologous platelet gel having beneficial geometric shapes and methods of making the same
CA2449436C (en) 2001-06-22 2012-05-01 Millard Marsden Mershon Compositions and methods for reducing blood and fluid loss from open wounds
US6891077B2 (en) 2001-07-25 2005-05-10 The United States Of America As Represented By The Secretary Of The Army Fibrinogen bandages and arterial bleeding models and methods of making and using thereof
DE10142918A1 (de) 2001-09-01 2003-05-22 Beiersdorf Ag Selbstklebende Gelmatrix auf Polyacrylsäurebasis
US7198786B2 (en) 2001-10-12 2007-04-03 Baxter International Inc. Method for the reduction or prevention of post-surgical adhesion formation
KR100843001B1 (ko) 2002-01-16 2008-07-01 동화약품공업주식회사 구강점막 부착형 필름제제
US7846478B2 (en) 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
AU2003211376A1 (en) 2002-02-20 2003-09-09 New X-National Technology K.K. Drug administration method
US20100254900A1 (en) 2002-03-18 2010-10-07 Campbell Phil G Biocompatible polymers and Methods of use
NL1020426C2 (nl) 2002-04-18 2003-10-21 Tno Modificatie van de eigenschappen van een fibrinematrix met betrekking tot groei en ingroei van cellen.
WO2003092756A1 (en) 2002-04-30 2003-11-13 Her Majesty The Queen, In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Multi-layer synthetic dressing with cooling characteristics
RS20050051A (sr) 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Farmaceutski aktivni sastojak preparata i medikamenata koji sadrže trombin ili imaju mogućnost stvaranja trombina
DE10261126A1 (de) 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
US20050064042A1 (en) * 2003-04-29 2005-03-24 Musculoskeletal Transplant Foundation Cartilage implant plug with fibrin glue and method for implantation
AU2004257132B2 (en) 2003-07-18 2008-02-21 Agency For Science, Technology And Research Thermosensitive polymers for therapeutic use and methods of preparation
WO2005072700A2 (en) 2004-01-30 2005-08-11 Ferrosan A/S Haemostatic sprays and compositions
RU2396985C2 (ru) 2004-08-03 2010-08-20 Тиссьюмед Лимитед Материалы, обладающие адгезией к тканям
US7399800B2 (en) 2005-04-15 2008-07-15 E.I. Du Pont De Nemours And Company Temperature switchable adhesives comprising crystallizable abietic acid derivative-based tackifiers
WO2007139028A1 (ja) * 2006-05-29 2007-12-06 Kaneka Corporation 分離材料およびそれを用いた細胞等の採取方法
WO2008127287A2 (en) 2006-10-11 2008-10-23 Biolife, L.L.C. Materials and methods for wound treatment
US8029532B2 (en) * 2006-10-11 2011-10-04 Cook Medical Technologies Llc Closure device with biomaterial patches
US7968682B2 (en) 2006-12-12 2011-06-28 Oregon Health & Science University Degradation-resistant fibrinogen sealants
US20100316712A1 (en) * 2006-12-22 2010-12-16 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
US20090075891A1 (en) 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
US20090099149A1 (en) 2007-10-11 2009-04-16 Wyeth Bioadhesive film
US20110054375A1 (en) 2007-11-27 2011-03-03 Hans Smola Dressing comprising polyacrylate particles and use thereof
US8299316B2 (en) 2007-12-18 2012-10-30 Ethicon, Inc. Hemostatic device
US20090324714A1 (en) 2008-06-27 2009-12-31 Wyeth Dual adhesive technology
US20100087768A1 (en) 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
US9056047B2 (en) * 2008-10-31 2015-06-16 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8314211B2 (en) 2009-04-07 2012-11-20 George Falus Tissue sealant for use in non compressible hemorrhage
ITPI20090066A1 (it) * 2009-05-26 2010-11-27 Consiglio Nazionale Ricerche Metodo per produrre un dispositivo applicabile a tessuti biologici, in particolare un patch per trattare tessuti danneggiati, e dispositivo ottenuto con tale metodo
EP2264082A1 (de) 2009-06-19 2010-12-22 BYK-Chemie GmbH Terminal ungesättigte, glycidol-basierte Markomonomere, daraus erhältliche Polymere, Herstellung und Verwendung
WO2011035020A1 (en) * 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US20110152924A1 (en) * 2009-12-22 2011-06-23 Michel Gensini Oxidized regenerated cellulose adhesive tape
US20120052234A1 (en) 2010-08-30 2012-03-01 Sriram Natarajan Adhesive structure with stiff protrusions on adhesive surface
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
US20140222067A1 (en) 2013-02-01 2014-08-07 Xcede Technologies, Inc. Minimally invasive surgery, including vascular closure, and associated sealants
EP2968651B1 (en) 2013-03-15 2020-10-21 Cook Medical Technologies LLC Adhesive medical products and methods for treating gastrointestinal lesions
CA2956693A1 (en) 2014-08-08 2016-02-11 Xcede Technologies, Inc. Adhesive compositions and patches, and associated systems, kits, and methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Also Published As

Publication number Publication date
US20210038758A1 (en) 2021-02-11
EP2809362A2 (en) 2014-12-10
AU2017201762A1 (en) 2017-04-06
US20130202675A1 (en) 2013-08-08
US9352067B2 (en) 2016-05-31
US20130202656A1 (en) 2013-08-08
US20150231299A1 (en) 2015-08-20
AU2013214974B2 (en) 2016-12-22
JP2015506256A (ja) 2015-03-02
US20160296657A1 (en) 2016-10-13
AU2013214974A1 (en) 2014-09-18
US8999376B2 (en) 2015-04-07
KR20140121873A (ko) 2014-10-16
WO2013116633A2 (en) 2013-08-08
US9956311B2 (en) 2018-05-01
US20190060510A1 (en) 2019-02-28
US20130202674A1 (en) 2013-08-08
WO2013116633A3 (en) 2013-10-10
JP6329084B2 (ja) 2018-05-23

Similar Documents

Publication Publication Date Title
US20210038758A1 (en) Tissue patch
US20140222067A1 (en) Minimally invasive surgery, including vascular closure, and associated sealants
AU2011232907B2 (en) Tissue sealant for use in non compressible hemorrhage
US10179145B2 (en) Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
AU2011232907A1 (en) Tissue sealant for use in non compressible hemorrhage
US8680240B1 (en) Tissue sealant for use in non-compressible hemorrhage
JP2010504410A (ja) 組織接着剤組成物およびその方法
CN115814163A (zh) Peg双组分自粘性可吸收生物补片及其制备方法和应用
CN114848668B (zh) 具有促进伤口愈合和快速止血功能的组合物
CN113599566B (zh) 一种疏水性高分子止血修复材料、其制备方法及应用
WO2018119320A1 (en) Hemostatic compositions with antifibrinolytic agents
WO2019119019A1 (en) Multi-layer haemostat patch comprising beta-chitin
CA3255151A1 (en) HEMOSTATIC BIOADHESIVE

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180129

FZDE Discontinued

Effective date: 20200831